Primary immune-mediated thrombocytopenia in cats

J Am Anim Hosp Assoc. 2010 Jan-Feb;46(1):12-9. doi: 10.5326/0460012.

Abstract

Feline primary immune-mediated thrombocytopenia (pIMT) is a rare condition, and only a few cases have been described in veterinary literature. Five cats with severe thrombocytopenia most likely due to pIMT are described. A flow cytometry platelet-bound antibody test was positive in all cats; underlying diseases or triggering factors causing thrombocytopenia were not detected. Three cats were transfused with blood type-compatible fresh whole blood; one cat received Oxyglobin as well. All cats were treated with prednisolone; one cat received chlorambucil in addition. Four cats responded to treatment and were discharged from the hospital. One cat was euthanized due to dyspnea. Primary immune-mediated thrombocytopenia is rarely diagnosed in cats, but it is important as a differential diagnosis in cats presented with surface bleeding.

MeSH terms

  • Animals
  • Autoantibodies / blood*
  • Autoimmune Diseases / blood
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / therapy
  • Autoimmune Diseases / veterinary*
  • Blood Platelets / immunology*
  • Blood Transfusion / veterinary
  • Cat Diseases / blood*
  • Cat Diseases / immunology*
  • Cat Diseases / therapy
  • Cats
  • Female
  • Flow Cytometry
  • Hemoglobins / therapeutic use
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Platelet Count / veterinary
  • Prednisolone / therapeutic use
  • Thrombocytopenia / immunology
  • Thrombocytopenia / therapy
  • Thrombocytopenia / veterinary*
  • Treatment Failure
  • Treatment Outcome

Substances

  • Autoantibodies
  • Hemoglobins
  • Immunosuppressive Agents
  • hemoglobin glutamer-200
  • Prednisolone